3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
2
Dermatologic
2
Thoracic
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Carcinoma, Renal Cell
62
Prostatic Neoplasms
35
Kidney Neoplasms
18
Carcinoma, Transitional Cell
17
Melanoma
15
Urinary Bladder Neoplasms
14
Neoplasm Metastasis
12
Carcinoma, Non-Small-Cell Lung
12
Clear-cell metastatic renal cell carcinoma
11
Colorectal Neoplasms
9
Neoplasms
8
Carcinoma, Hepatocellular
8
Squamous Cell Carcinoma of Head and Neck
7
Triple Negative Breast Neoplasms
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Uterine Cervical Neoplasms
5
Stomach Neoplasms
5
Pancreatic Neoplasms
5
Urogenital Neoplasms
4
Small Cell Lung Carcinoma
4
Endometrial Neoplasms
4
Carcinoma, Merkel Cell
4
Urethral Neoplasms
3
Penile Neoplasms
3
Neuroblastoma
3
Liver Neoplasms
3
Brain Neoplasms
3
Wilms Tumor
2
Ureteral Neoplasms
2
Interventions
Peripheral Blood Stem Cell Transplantation
6
Cyclophosphamide
6
fludarabine phosphate
5
Nivolumab
5
Mycophenolic Acid
5
Carboplatin
5
Whole-Body Irradiation
4
Radiotherapy
4
Filgrastim
4
Cyclosporine
4
Gemcitabine
3
Cisplatin
3
Busulfan
3
Antilymphocyte Serum
3
cabozantinib
2
cabazitaxel
2
Voriconazole
2
Thiotepa
2
Therapeutics
2
Standard of Care
2
Sirolimus
2
Polymerase Chain Reaction
2
Mitomycin
2
Methylprednisolone
2
Methotrexate
2
Melphalan
2
Itraconazole
2
Immunoglobulin G
2
Goserelin
2
Flow Cytometry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Ipilimumab
×
Genitourinary
×
Clear all
NCT03138512
2024-12-18
CheckMate 914
Bristol-Myers Squibb
Phase 3
Completed
1,641 enrolled
21 charts